Hot Topics in Epigenetic Regulation of Cancer Self-Renewal for Pancreatic Tumors: Future Trends
- 29 January 2019
- journal article
- editorial
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (7) , 683-685
Abstract
No abstract availableKeywords
Funding Information
- National Research Council (402621/2016-6, 105899)
This publication has 16 references indexed in Scilit:
- Pancreatic cancer circulating tumor cells: applications for personalized oncologyExpert Review of Molecular Diagnostics, 2018
- The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancerFuture Oncology, 2017
- Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer DiagnosisThe Journal of Molecular Diagnostics, 2017
- A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort studyOncotarget, 2016
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Nivolumab for advanced squamous cell lung cancer: what are the next steps?The Lancet Oncology, 2015
- Whole genomes redefine the mutational landscape of pancreatic cancerNature, 2015
- Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular studyThe Lancet Oncology, 2013
- Considerations in the development of circulating tumor cell technology for clinical useJournal of Translational Medicine, 2012
- Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformationThe Journal of Pathology, 2005